Diaceutics 

$2.31
11
+$0.00+0%星期三 17:40

統計

當日最高
2
當日最低
2
52週高點
2.51
52週低點
1.3672
成交量
3,500
平均成交量
0
市值
195.98M
本益比
0
股息殖利率
-
股息
-

即將到來

財報

9月22日預期
Q2 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
Q2 2026
-3.65
-0.93
1.78
4.5
預期EPS
-2.781452785229366
實際EPS
-3.248538177948954

財務

0.12%利潤率
有盈利
2020
2021
2022
2023
2024
2025
52.1M營收
62,433.42淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 DIUXF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Diaceutics PLC, established in 2005 and headquartered in Belfast, UK, is a company dedicated to accelerating the commercialization of diagnostic solutions. It offers global pharmaceutical companies comprehensive data, advanced analytics, and implementation support. Central to its operations is the DXRX platform. This platform features DXRX data solutions, providing access to extensive diagnostic testing data pipelines from a broad network of laboratories, including real-time DXRX signal alerts, lab and physician mapping, and a testing dashboard. The DXRX platform also hosts a marketplace where laboratories, pharmaceutical firms, and diagnostic companies can connect to collaborate on precision medicine diagnostics. Diaceutics further provides DXRX Patient Journey, a tool for pharmaceutical clients to conduct detailed longitudinal analyses of individual patient biomarker testing paths, helping identify opportunities for earlier intervention and treatment. DXRX Lab Benchmarking allows laboratories to sharpen their competitive edge by comparing their key criteria against industry counterparts, encompassing metrics such as disease focus, testing methodologies, market share, turnaround times, and their standing as leaders in specific diagnostic fields. The DXRX Test Reimbursement service assists pharma clients in funding novel companion diagnostics, thereby shortening the time required for their widespread adoption. Furthermore, DXRX Test Signal delivers immediate notifications of testing events, empowering pharmaceutical clients to swiftly identify therapeutically actionable patients. Beyond the platform, Diaceutics furnishes services for diagnostic landscape analysis, strategic planning, implementation, and ongoing tracking, alongside expert consulting tailored to precision medicine diagnostics. Its extensive service portfolio also covers test standardization, quality evaluations, optimization of test reports, technical laboratory support, assistance with test access and reimbursement, laboratory training, and various educational resources.
顯示更多
執行長
Ryan Keeling
員工
205
國家
愛爾蘭
ISIN
GB00BJQTGV64
WKN
000A2PF80

上市

0 則留言

分享你的想法

常見問題

Diaceutics 今天的股價是多少?▼
DIUXF 目前價格為 $2.31 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Diaceutics 股價表現。
Diaceutics 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Diaceutics 的股票以代號 DIUXF 進行交易。
Diaceutics 的股價在上漲嗎?▼
DIUXF 股票較上週上漲 +0%,本月上漲 +0%,過去一年 Diaceutics 上漲 +68.67%。
Diaceutics 的市值是多少?▼
今天 Diaceutics 的市值為 195.98M
Diaceutics 下一次財報日期是什麼時候?▼
Diaceutics 將於 2027年3月15日 公布下一次財報。
Diaceutics 上一季度的財報如何?▼
DIUXF 上一季度的財報為每股 -0.04 USD,預估為 -0.04 USD,帶來 -16.79% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Diaceutics 去年的營收是多少?▼
Diaceutics 去年的營收為 52.1MUSD。
Diaceutics 去年的淨利是多少?▼
DIUXF 去年的淨收益為 62,433.42USD。
Diaceutics 有多少名員工?▼
截至 2026年11月22日,公司共有 205 名員工。
Diaceutics 位於哪個產業?▼
Diaceutics從事於Health & Wellness產業。
Diaceutics 何時完成拆股?▼
Diaceutics 最近沒有進行任何拆股。
Diaceutics 的總部在哪裡?▼
Diaceutics 的總部位於 愛爾蘭 的 Belfast。